About Autonomize
Autonomize is a company based in Austin (United States) founded in 2021 by Ganesh Padmanabhan and Kris Nair. Autonomize has raised $32.02 million across 2 funding rounds from investors including Valtruis, Next Practices Group and Asset Management Ventures. Autonomize offers products and services including Prior Authorization Copilot, Care Gaps Review, Medical Record Review, Care Management, and Complex Document Processing. Autonomize operates in a competitive market with competitors including Medidata, Verily, TriNetX, Signant Health and WIRB-Copernicus Group, among others.
- Headquarter Austin, United States
- Founders Ganesh Padmanabhan, Kris Nair
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Autonomize Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$32.02 M (USD)
in 2 rounds
-
Latest Funding Round
$28 M (USD), Series A
May 28, 2025
-
Investors
Valtruis
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Autonomize
Autonomize offers a comprehensive portfolio of products and services, including Prior Authorization Copilot, Care Gaps Review, Medical Record Review, Care Management, and Complex Document Processing.
Automates extraction and summarization of authorization requests for faster decisions.
Identifies and addresses care gaps using patient data for better outcomes.
Transforms unstructured medical data into structured insights for decision-making.
Compiles case summaries from various sources to support informed patient care.
Structures and summarizes documents like contracts for actionable workflows.
People of Autonomize
Unlock access to complete
Funding Insights of Autonomize
Autonomize has successfully raised a total of $32.02M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $28 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Autonomize
Autonomize has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Valtruis, Next Practices Group and Asset Management Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage US companies are invested in by Asset Management Ventures.
|
Locked | Locked | Locked | |
|
Early-stage venture capital investments are made by ATX Venture Partners.
|
Locked | Locked | Locked | |
|
Loop Ventures is involved in venture capital activities.
|
Locked | Locked | Locked |
Investor details for Autonomize
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Autonomize
Investment portfolio details for Autonomize
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Autonomize
Detailed financials for Autonomize
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Autonomize Comparisons
Peer comparison for Autonomize
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Autonomize
Autonomize operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medidata, Verily, TriNetX, Signant Health and WIRB-Copernicus Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
|
|
| Locked | Locked | Locked |
AI-based solutions for health management are provided.
|
|
| Locked | Locked | Locked |
Clinical trial management software is provided for researchers and professionals.
|
|
| Locked | Locked | Locked |
Signant Health is engaged in providing clinical trial technology solutions.
|
|
| Locked | Locked | Locked |
Regulatory and ethical review services for clinical research are provided.
|
|
| Locked | Locked | Locked |
AI enabled solutions for clinical trials
|
Detailed competitors of Autonomize
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Autonomize
Complete news archive for Autonomize
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Autonomize
Autonomize was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Autonomize is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Autonomize is a funded company, having raised a total of $32.02M across 2 funding rounds to date.
Autonomize was founded in 2021 and is based in Austin, United States. Operations focus on the biotechnology sector, where AI-driven software is provided to researchers for drug targeting, toxicity assessment, and clinical trial management. Features include handling of biomedical and clinical data, along with workflow tools to support research processes. The platform aids in streamlining drug development activities.
Autonomize offers Prior Authorization Copilot, Care Gaps Review, Medical Record Review, Care Management, and Complex Document Processing.
Autonomize has 8 investors. Key investors include Valtruis, Next Practices Group, Asset Management Ventures, ATX Venture Partners, and Loop Ventures.